Arcellx Stock

Arcellx Equity

Delisted·Apr 29, 2026

The The Equity of Arcellx (ACLX) as of Aug 3, 2026 is 402.35 M USD. In the previous year, The Equity was 454.79 M USD — a change of -11.53% (lower).

Equity

402.35 MUSD

YoY

-11.53%

Last updated:

In 2026, Arcellx's equity was 402.35 M USD, a -11.53% increase from the 454.79 M USD equity in the previous year.

Access this data via the Eulerpool API

Arcellx Stock analysis

What does Arcellx do? Arcellx is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Arcellx's Equity

Arcellx's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Arcellx's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Arcellx's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Arcellx's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Arcellx’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Arcellx stock

The Equity of Arcellx is 402.35 M USD in 2026.

Access this data via the Eulerpool API

Balance Sheet — Arcellx

All Key Metrics — Arcellx